Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1743965
Max Phase: Preclinical
Molecular Formula: C12H14Cl2N4
Molecular Weight: 248.72
Molecule Type: Small molecule
Associated Items:
ID: ALA1743965
Max Phase: Preclinical
Molecular Formula: C12H14Cl2N4
Molecular Weight: 248.72
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Clc1cccc2nc(N3CCNCC3)cnc12
Standard InChI: InChI=1S/C12H13ClN4.ClH/c13-9-2-1-3-10-12(9)15-8-11(16-10)17-6-4-14-5-7-17;/h1-3,8,14H,4-7H2;1H
Standard InChI Key: CWAKGFFOXUOKLX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 248.72 | Molecular Weight (Monoisotopic): 248.0829 | AlogP: 1.69 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.05 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.74 | CX LogP: 2.07 | CX LogD: 0.72 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.83 | Np Likeness Score: -1.59 |
1. Lumma WC, Hartman RD, Saari WS, Engelhardt EL, Lotti VJ, Stone CA.. (1981) Piperazinylquinoxalines with central serotoninmimetic activity., 24 (1): [PMID:6451700] [10.1021/jm00133a019] |
Source(1):